ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

BSA Approves Provocative Questions RFA; NCI Announces Review of SAIC-Frederick, for caBIG Restructuring

June 24, 2011

2006 demonstration project to pay $23 per office visit.

November 4, 2005

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

NCI-Approved CTEP Trials For The Month of June

June 29, 2012